74 related articles for article (PubMed ID: 26862298)
1. Innovations in Peripheral Nerve Regeneration.
Lam TC; Leung YY
Bioengineering (Basel); 2024 Apr; 11(5):. PubMed ID: 38790310
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin in Optic Neuropathies: Current Future Strategies for Optic Nerve Protection and Repair.
Lai YF; Lin TY; Ho PK; Chen YH; Huang YC; Lu DW
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806148
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Erythropoietin and Its Derivatives on Ischemic Stroke Therapy: A Comprehensive Review.
Ma Y; Zhou Z; Yang GY; Ding J; Wang X
Front Pharmacol; 2022; 13():743926. PubMed ID: 35250554
[TBL] [Abstract][Full Text] [Related]
4. Expanding the MECP2 network using comparative genomics reveals potential therapeutic targets for Rett syndrome.
Unterman I; Bloch I; Cazacu S; Kazimirsky G; Ben-Zeev B; Berman BP; Brodie C; Tabach Y
Elife; 2021 Aug; 10():. PubMed ID: 34355696
[TBL] [Abstract][Full Text] [Related]
5. Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
Soliz J; Schneider-Gasser EM; Arias-Reyes C; Aliaga-Raduan F; Poma-Machicao L; Zubieta-Calleja G; Furuya WI; Trevizan-Baú P; Dhingra RR; Dutschmann M
Respir Physiol Neurobiol; 2020 Aug; 279():103476. PubMed ID: 32522574
[TBL] [Abstract][Full Text] [Related]
6. CEPO (carbamylated erythropoietin)-Fc protects hippocampal cells in culture against beta amyloid-induced apoptosis: considering Akt/GSK-3β and ERK signaling pathways.
Hooshmandi E; Moosavi M; Katinger H; Sardab S; Ghasemi R; Maghsoudi N
Mol Biol Rep; 2020 Mar; 47(3):2097-2108. PubMed ID: 32067159
[TBL] [Abstract][Full Text] [Related]
7. PEGylated Erythropoietin Protects against Brain Injury in the MCAO-Induced Stroke Model by Blocking NF-κB Activation.
Im JH; Yeo IJ; Hwang CJ; Lee KS; Hong JT
Biomol Ther (Seoul); 2020 Mar; 28(2):152-162. PubMed ID: 31813204
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of EpoL against oxidative stress induced by soluble oligomers of Aβ peptide.
Castillo C; Fernández-Mendívil C; Buendia I; Saavedra P; Meza C; Parra NC; Lopez MG; Toledo JR; Fuentealba J
Redox Biol; 2019 Jun; 24():101187. PubMed ID: 30965198
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Review of Neuroprotective Strategies in the Management of Hypoglycemia.
Nistor M; Schmidt M; Graul I; Rakers F; Schiffner R
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696060
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective Agents in the Intensive Care Unit: -Neuroprotective Agents in ICU.
Panahi Y; Mojtahedzadeh M; Najafi A; Rajaee SM; Torkaman M; Sahebkar A
J Pharmacopuncture; 2018 Dec; 21(4):226-240. PubMed ID: 30652049
[TBL] [Abstract][Full Text] [Related]
11. Carbamylated Erythropoietin Decreased Proliferation and Neurogenesis in the Subventricular Zone, but Not the Dentate Gyrus, After Irradiation to the Developing Rat Brain.
Osato K; Sato Y; Osato A; Sato M; Zhu C; Leist M; Kuhn HG; Blomgren K
Front Neurol; 2018; 9():738. PubMed ID: 30258396
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin Attenuates Postoperative Cognitive Dysfunction by Shifting Macrophage Activation toward the M2 Phenotype.
Lee JH; Kam EH; Kim SY; Cheon SY; Kim EJ; Chung S; Jeong JH; Koo BN
Front Pharmacol; 2017; 8():839. PubMed ID: 29201007
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor.
Hernández CC; Burgos CF; Gajardo AH; Silva-Grecchi T; Gavilan J; Toledo JR; Fuentealba J
Neural Regen Res; 2017 Sep; 12(9):1381-1389. PubMed ID: 29089974
[TBL] [Abstract][Full Text] [Related]
14. Inflammogenesis of Secondary Spinal Cord Injury.
Anwar MA; Al Shehabi TS; Eid AH
Front Cell Neurosci; 2016; 10():98. PubMed ID: 27147970
[TBL] [Abstract][Full Text] [Related]
15. Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection.
Chen J; Yang Z; Zhang X
Biochem Insights; 2015; 8(Suppl 1):25-9. PubMed ID: 26862298
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection and CD131/GDNF/AKT Pathway of Carbamylated Erythropoietin in Hypoxic Neurons.
Ding J; Wang J; Li QY; Yu JZ; Ma CG; Wang X; Lu CZ; Xiao BG
Mol Neurobiol; 2017 Sep; 54(7):5051-5060. PubMed ID: 27541284
[TBL] [Abstract][Full Text] [Related]
17. Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury.
Adembri C; Massagrande A; Tani A; Miranda M; Margheri M; De Gaudio R; Pellegrini-Giampietro DE
Crit Care Med; 2008 Mar; 36(3):975-8. PubMed ID: 18176311
[TBL] [Abstract][Full Text] [Related]
18. The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease.
Thomas Tayra J; Kameda M; Yasuhara T; Agari T; Kadota T; Wang F; Kikuchi Y; Liang H; Shinko A; Wakamori T; Vcelar B; Weik R; Date I
Brain Res; 2013 Mar; 1502():55-70. PubMed ID: 23380533
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
